ATE412411T1 - Pmcol zur behandlung von prostatakrebs - Google Patents
Pmcol zur behandlung von prostatakrebsInfo
- Publication number
- ATE412411T1 ATE412411T1 AT04785845T AT04785845T ATE412411T1 AT E412411 T1 ATE412411 T1 AT E412411T1 AT 04785845 T AT04785845 T AT 04785845T AT 04785845 T AT04785845 T AT 04785845T AT E412411 T1 ATE412411 T1 AT E412411T1
- Authority
- AT
- Austria
- Prior art keywords
- androgen
- prostate cancer
- pmcol
- treatment
- alleviation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45051003P | 2003-02-27 | 2003-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412411T1 true ATE412411T1 (de) | 2008-11-15 |
Family
ID=34115267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04785845T ATE412411T1 (de) | 2003-02-27 | 2004-02-27 | Pmcol zur behandlung von prostatakrebs |
Country Status (9)
Country | Link |
---|---|
US (6) | US7709525B2 (de) |
EP (1) | EP1596857B1 (de) |
AT (1) | ATE412411T1 (de) |
AU (1) | AU2004260631B2 (de) |
CA (1) | CA2517390C (de) |
DE (1) | DE602004017425D1 (de) |
ES (1) | ES2314451T3 (de) |
HK (1) | HK1088214A1 (de) |
WO (1) | WO2005011658A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011658A2 (en) * | 2003-02-27 | 2005-02-10 | Wisconsin Alumni Research Foundation | Chroman-derivated anti-androgens for treatment of androgen-mediated disorders |
US7507425B2 (en) * | 2005-09-27 | 2009-03-24 | The Quigley Corporation | Method for the treatment of cachexia |
AR060748A1 (es) * | 2006-05-03 | 2008-07-10 | Wisconsin Alumni Res Found | Compuestos de n1, n4- bis ( buta-1,3- dienil) butano-1,4- diamina y metodos de tratamiento de los mismos |
WO2008060949A2 (en) * | 2006-11-09 | 2008-05-22 | Stc.Unm | Compounds with anti-androgenic activity and the use thereof |
KR102221365B1 (ko) * | 2019-05-07 | 2021-03-02 | (주)케어젠 | 트롤록스-펩타이드 결합체 및 그의 용도 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3995060A (en) | 1972-06-20 | 1976-11-30 | Schering Corporation | Antiandrogenic agents and method for the treatment of androgen dependent disease states |
US4474813A (en) | 1980-10-24 | 1984-10-02 | Schering Corporation | Pharmaceutical preparations comprising flutamide |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
US4897256A (en) | 1986-11-25 | 1990-01-30 | Abbott Laboratories | LHRH analog formulations |
US5023088A (en) | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
GB9112859D0 (en) | 1991-06-14 | 1991-07-31 | Ici Plc | Peptide process |
EP0852615B1 (de) * | 1996-07-25 | 2005-12-14 | DuPont Air Products NanoMaterials L.L.C. | Zusammensetzung und verfahren zum chemisch-mechanischen polieren |
US5958967A (en) | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
JPH10168095A (ja) * | 1996-12-10 | 1998-06-23 | Cci Corp | 炎症性腸疾患予防および治療剤 |
GB9702310D0 (en) * | 1997-02-05 | 1997-03-26 | Univ Hertfordshire | Invention |
US6187811B1 (en) * | 1998-10-28 | 2001-02-13 | Lipogenics, Inc. | Methods for treating benign prostatic hyperplasia using tocotrienols |
US6048891A (en) * | 1998-12-17 | 2000-04-11 | Loma Linda University Medical Center | Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease |
AU2323700A (en) | 1999-02-02 | 2000-08-25 | Cci Corporation | Preventive and therapeutic agents for arteriosclerosis |
US6350776B1 (en) * | 1999-09-20 | 2002-02-26 | Angelo Manfredo Azzi | Method of treating proliferative disease with lycopene and alpha-tocopherol |
WO2005011658A2 (en) * | 2003-02-27 | 2005-02-10 | Wisconsin Alumni Research Foundation | Chroman-derivated anti-androgens for treatment of androgen-mediated disorders |
-
2004
- 2004-02-27 WO PCT/US2004/005872 patent/WO2005011658A2/en active Application Filing
- 2004-02-27 ES ES04785845T patent/ES2314451T3/es not_active Expired - Lifetime
- 2004-02-27 CA CA2517390A patent/CA2517390C/en not_active Expired - Fee Related
- 2004-02-27 US US10/789,835 patent/US7709525B2/en not_active Expired - Fee Related
- 2004-02-27 DE DE602004017425T patent/DE602004017425D1/de not_active Expired - Lifetime
- 2004-02-27 AT AT04785845T patent/ATE412411T1/de active
- 2004-02-27 EP EP04785845A patent/EP1596857B1/de not_active Expired - Lifetime
- 2004-02-27 AU AU2004260631A patent/AU2004260631B2/en not_active Ceased
-
2006
- 2006-05-08 HK HK06105362.3A patent/HK1088214A1/xx not_active IP Right Cessation
-
2008
- 2008-05-29 US US12/129,338 patent/US7863324B2/en not_active Expired - Fee Related
-
2009
- 2009-10-19 US US12/581,501 patent/US20100056619A1/en not_active Abandoned
-
2012
- 2012-07-05 US US13/542,432 patent/US8536219B2/en not_active Expired - Fee Related
-
2013
- 2013-08-14 US US13/966,775 patent/US8809387B2/en not_active Expired - Fee Related
-
2014
- 2014-07-10 US US14/327,942 patent/US9440942B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090326055A1 (en) | 2009-12-31 |
EP1596857A2 (de) | 2005-11-23 |
US8809387B2 (en) | 2014-08-19 |
DE602004017425D1 (de) | 2008-12-11 |
US7709525B2 (en) | 2010-05-04 |
US20120277301A1 (en) | 2012-11-01 |
US20140323560A1 (en) | 2014-10-30 |
HK1088214A1 (en) | 2006-11-03 |
AU2004260631A1 (en) | 2005-02-10 |
US8536219B2 (en) | 2013-09-17 |
CA2517390A1 (en) | 2005-02-10 |
US7863324B2 (en) | 2011-01-04 |
AU2004260631B2 (en) | 2009-08-06 |
CA2517390C (en) | 2012-01-17 |
EP1596857B1 (de) | 2008-10-29 |
US20100056619A1 (en) | 2010-03-04 |
US20050192342A1 (en) | 2005-09-01 |
US9440942B2 (en) | 2016-09-13 |
WO2005011658A2 (en) | 2005-02-10 |
US20140045929A1 (en) | 2014-02-13 |
ES2314451T3 (es) | 2009-03-16 |
WO2005011658A3 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
TW200510303A (en) | Novel compounds | |
WO2006034154A3 (en) | Salts of 5-azacytidine | |
TW200730515A (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
IL217623A (en) | Amino-carbonyl-boron compound is converted | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
TW200700071A (en) | Novel use | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
MX2010003269A (es) | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
HK1088214A1 (en) | Pmcol for the treatment of prostate cancer | |
GEP20053590B (en) | Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors | |
WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1596857 Country of ref document: EP |